← Leaderboards
Kimberly M Jackson
Spelman College
$1,302,404
Attributed
$1,398,341
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $277.5K · FY2007–13$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,398,341 · 2
By mechanism
P20$1,398,341 · 2
Top collaborators
- Leyte L Winfield1 shared
Most similar at Spelman College
Same institution · by research overlap
- Jakita O Thomas$1,405,277
- Leyte L Winfield$1,464,106
Others in their field
Top investigators on “G1 Phase”
- Bruce W Stillman · Cold Spring Harbor Laboratory$13,189,933
- E Premkumar Reddy · Temple University$8,639,868
- Piotr Sicinski · Dana-Farber Cancer Inst$8,496,917
- Jan M Skotheim · Stanford University$8,390,205
- Richard Assoian · University Of Pennsylvania$8,277,563
- Jeanette Gowen Cook · Duke University$8,114,411
Research focus
G1 PhaseDisease ProgressionEffectivenessDrug Delivery SystemsDibenzoylmethaneAndrogensComplexDoseAntineoplastic AgentsCommunitiesDetectionAffectCancer CellCancer EtiologyAntiandrogen TherapyCell CycleCellsCessation Of LifeChemopreventionChemotherapeutic AgentBaseAfrican AmericanAndrogen ReceptorHormones
Grant awards (6)
Women of color Legacy Project (WCL)$191,875
P20 · FY2013 · MD · contact PI
Development of New therapies for Advanced Prostate Cancer$195,277
P20 · FY2011 · MD · contact PI
Development of New therapies for Advanced Prostate Cancer$251,632
P20 · FY2010 · MD · contact PI
Development of New therapies for Advanced Prostate Cancer$245,720
P20 · FY2009 · MD · contact PI
Development of New therapies for Advanced Prostate Cancer$236,359
P20 · FY2008 · MD · contact PI
Development of New therapies for Advanced Prostate Cancer$277,478
P20 · FY2007 · MD · contact PI